Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

At one point in my so-called investment of Algernon (formerly Breathtec Biomedical), I had a targeted share price of $3 USD to exit with my targeted profit amount.

That number changed to a targeted share price of $10 USD upon the 1st reverse split by Moreau.

That number changed to an unrealistic targeted share price of $900 USD upon the 2nd reverse split by Moreau.

From $3 price target to $10 price target to $900 price target.

Those numbers represent the reduction/destruction of shares per reverse splits and subsequent and pending reconstruction/increase of outstanding shares/dilution.

Moreau has mastered the art of screwing you over a barrel - stuffing you inside the barrel - kicking the barrel over Niagara Falls.

Surely, I'm very interested in simply getting to a fire sale $30 USD price target and finally ascending from Purgatory.

Get us to $30 USD Moreau and your ilk will never see another post from me - on any message board - for any of your penny play stocks including those publicly run by the Wizard Of Deception - King Cobra.

A strictly a business word of advice - Management should have secured the AlgernonPharma.com web domain. Everyone knows a 5 character or less domain name is most desirable from a business standpoint. That would appear to be relevant to management by simply looking at Algernon Pharmaceuticals official twitter page:

Algernon Pharmaceuticals@AlgernonPharma

twitter.com/AlgernonPharma?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

Algernon needs to revamp its corporate website. It's full of holes and its overall design is underwhelming to say the least. Reach out to a dynamic webpage builder. Take a page from Cybin or even GH Research. GH Research has a very clean and refreshing look. Algernon's website reminds me of AS SEEN ON TV infomercials with added stuff. Moreau’s in a bunch of video’s plastered throughout the website.

Revamping the Corporate website and purchasing the algernonpharma.com domain name would go a long way towards seeking investors seeking information about the company. You should strive to captivate your audience. You can't do that without keeping your website updated. It's good to see Algernon got around to adding a coherent Pipeline outline to the website. The Pipeline is the #1 public information one seeks to get a snapshot of what the hell a pharmaceutical company is tinkering with under the hood. The website is supposed to be a Window For The World to make a quick and reasonable assessment of what the hell Algernon has going for itself.

Is there no one in the family/friends plan Algernon can hire (tech geek) to meet the web page challenges of a company pursuing Psychedelics? You do know Psychedelic investors are like cult following pot Stock investors. They like VISUALS. They always opine a lot about their past and present use of drugs. Design a website that can draw in rabid psychedelic fans and they will go to war for you in the worst of times.

See MindMed as an example of rabid fans. There is no such link on their websites you will click on and get zero information. The same goes for Cybin and GH Research as further examples in the psych space. Follow the path of successful companies in the growing psych sector. Thus, a complete overhaul of Algernon’s website. It would be money well spent for pending and future endeavors.

In addition, management apparently believes showing less faces, faces that would include a woman (show diversity) is not important.

Top websites that heavily rely on name and face recognition:



In addition, management apparently believes showing less faces, faces that would include a very smart woman (showing diversity) is not important to Algernon's overall image.

Personally, I believe it’s less professional and less transparent in a world where a company named Facebook|Meta|Instagram dominates the World Wide Web.

Surely, companies like GH Research and Cybin and MindMed get the big picture.

www.ghres.com/company

cybin.com/our-team/

mindmed.co/team/


The only name on the following list with a photo at Algernonpharmaceuticals.com is Christopher J. Moreau.

Christopher J. Moreau
55
2018
CEO & Director

Harold J. F. Bloomfield
77
2021
Independent Chairman of the Board

Rajpaul Attariwala
54
2015
Independent Director

Mark Williams
50
2018
Director

Martin Kolb
-
2019
Member of Medical & Scientific Advisory Board

Mark Swaim
-
2020
Member of Medical & Scientific Advisory Board

Jacky Smith
-
2020
Member of Medical & Scientific Advisory Board

Howard W. Gutman
64
2020
Director

W. Bruce Rowlands
-
2022
Member of Business Advisory Board

www.investing.com/equities/breathtec-biomedical-company-profile


Anybody recall an official announcement of this director appointment?

W. Bruce Rowlands
Algernon has appointed W. Bruce Rowlands to its Business Advisory Board. Mr. Rowlands has extensive public company experience over the last 25 years and recently was the Chairman of Xortx Therapeutics, a Canadian Biotech company focused in kidney disease on whose board he served for almost 8 years. He also served as Vice President & Director of Dominick & Dominick Securities Canada, SVP Lorus Therapeutics, now Aptose Bioscience, and Chairman & CEO Eurocontrol Technics Group Inc.

algernonpharmaceuticals.com/business-advisory-board/

Mr. W.Bruce Rowlands appears to have taken the place of Howard Gutman, Howard Gutman (Ambassador) has taken the place of David Levine (a longstanding lapdog for King Cobra going back to the disastrous days of Breathtec Biomedical).

Meanwhile, management can start with some low hanging fruit to help the cause:

algernonpharma.com - Domain name appears to be registered for sale at GoDaddy.com

Give GoDaddy hell management.



R O T F L M A O

M$